United Kingdom

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

14 Jun 2019
Change (% chg)

¥4 (+0.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Yasukawa, Kenji 

Mr. Kenji Yasukawa has been serving as President, Chief Executive Officer and Representative Director in Astellas Pharma Inc. since April 1, 2018. He joined the Company in April 1986. His previous titles include Vice President, Executive Officer, Senior Executive Officer and Director of Product Strategy in the Company. He used to work for Yamanouchi Pharmaceutical Co., Ltd. and a subsidiary.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --